BridgeBio Pharma, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BBIO for the last quarter is 2.73 M USD, and it's 26.01% higher compared to the previous quarter. The net income of Q3 24 is -162.04 M USD.